Rivaroxaban or Aspirin As Thromboprophylaxis in Multiple Myeloma

Clinical trial NCT03428373 · UNKNOWN

Trial details

NCT number: NCT03428373
Sponsor: London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
Status: UNKNOWN
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Multiple Myeloma in Relapse Multiple Myeloma Progression Multiple Myeloma Stage II Multiple Myeloma Stage I Multiple Myeloma With Failed Remission Multiple Myeloma Stage III

Start date: 2019-01-17
Primary completion: 2023-12-01
Enrollment: 57

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.